Literature DB >> 25673831

Life extension factor klotho prevents mortality and enhances cognition in hAPP transgenic mice.

Dena B Dubal1, Lei Zhu2, Pascal E Sanchez2, Kurtresha Worden2, Lauren Broestl3, Erik Johnson2, Kaitlyn Ho4, Gui-Qiu Yu4, Daniel Kim4, Alexander Betourne3, Makoto Kuro-O5, Eliezer Masliah6, Carmela R Abraham7, Lennart Mucke1.   

Abstract

Aging is the principal demographic risk factor for Alzheimer disease (AD), the most common neurodegenerative disorder. Klotho is a key modulator of the aging process and, when overexpressed, extends mammalian lifespan, increases synaptic plasticity, and enhances cognition. Whether klotho can counteract deficits related to neurodegenerative diseases, such as AD, is unknown. Here we show that elevating klotho expression decreases premature mortality and network dysfunction in human amyloid precursor protein (hAPP) transgenic mice, which simulate key aspects of AD. Increasing klotho levels prevented depletion of NMDA receptor (NMDAR) subunits in the hippocampus and enhanced spatial learning and memory in hAPP mice. Klotho elevation in hAPP mice increased the abundance of the GluN2B subunit of NMDAR in postsynaptic densities and NMDAR-dependent long-term potentiation, which is critical for learning and memory. Thus, increasing wild-type klotho levels or activities improves synaptic and cognitive functions, and may be of therapeutic benefit in AD and other cognitive disorders.
Copyright © 2015 the authors 0270-6474/15/352358-14$15.00/0.

Entities:  

Keywords:  Alzheimer's disease; NMDA receptors; aging; cognition; klotho; mice

Mesh:

Substances:

Year:  2015        PMID: 25673831      PMCID: PMC4323521          DOI: 10.1523/JNEUROSCI.5791-12.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  107 in total

1.  Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network.

Authors:  Julie A Harris; Nino Devidze; Laure Verret; Kaitlyn Ho; Brian Halabisky; Myo T Thwin; Daniel Kim; Patricia Hamto; Iris Lo; Gui-Qiu Yu; Jorge J Palop; Eliezer Masliah; Lennart Mucke
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

2.  Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease.

Authors:  K Johnson-Wood; M Lee; R Motter; K Hu; G Gordon; R Barbour; K Khan; M Gordon; H Tan; D Games; I Lieberburg; D Schenk; P Seubert; L McConlogue
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

3.  Preventing Alzheimer's disease.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2012-09-21       Impact factor: 47.728

4.  Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress.

Authors:  Taku Nagai; Kiyofumi Yamada; Hyoung-Chun Kim; Yong-Sun Kim; Yukihiro Noda; Akihiro Imura; Yo-ichi Nabeshima; Toshitaka Nabeshima
Journal:  FASEB J       Date:  2002-11-15       Impact factor: 5.191

5.  High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation.

Authors:  L Mucke; E Masliah; G Q Yu; M Mallory; E M Rockenstein; G Tatsuno; K Hu; D Kholodenko; K Johnson-Wood; L McConlogue
Journal:  J Neurosci       Date:  2000-06-01       Impact factor: 6.167

6.  Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model.

Authors:  Laure Verret; Edward O Mann; Giao B Hang; Albert M I Barth; Inma Cobos; Kaitlyn Ho; Nino Devidze; Eliezer Masliah; Anatol C Kreitzer; Istvan Mody; Lennart Mucke; Jorge J Palop
Journal:  Cell       Date:  2012-04-27       Impact factor: 41.582

7.  Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy.

Authors:  Rimante Minkeviciene; Sylvain Rheims; Marton B Dobszay; Misha Zilberter; Jarmo Hartikainen; Lívia Fülöp; Botond Penke; Yuri Zilberter; Tibor Harkany; Asla Pitkänen; Heikki Tanila
Journal:  J Neurosci       Date:  2009-03-18       Impact factor: 6.167

8.  Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein.

Authors:  Julie A Harris; Nino Devidze; Brian Halabisky; Iris Lo; Myo T Thwin; Gui-Qiu Yu; Dale E Bredesen; Eliezer Masliah; Lennart Mucke
Journal:  J Neurosci       Date:  2010-01-06       Impact factor: 6.167

9.  Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

Authors:  Jorge J Palop; Jeannie Chin; Erik D Roberson; Jun Wang; Myo T Thwin; Nga Bien-Ly; Jong Yoo; Kaitlyn O Ho; Gui-Qiu Yu; Anatol Kreitzer; Steven Finkbeiner; Jeffrey L Noebels; Lennart Mucke
Journal:  Neuron       Date:  2007-09-06       Impact factor: 17.173

10.  Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models.

Authors:  Irene H Cheng; Kimberly Scearce-Levie; Justin Legleiter; Jorge J Palop; Hilary Gerstein; Nga Bien-Ly; Jukka Puoliväli; Sylvain Lesné; Karen H Ashe; Paul J Muchowski; Lennart Mucke
Journal:  J Biol Chem       Date:  2007-06-04       Impact factor: 5.157

View more
  67 in total

Review 1.  Mini-review: Retarding aging in murine genetic models of neurodegeneration.

Authors:  Roger L Albin; Richard A Miller
Journal:  Neurobiol Dis       Date:  2015-10-21       Impact factor: 5.996

2.  Age-Related Differences in Brain Morphology and the Modifiers in Middle-Aged and Older Adults.

Authors:  Lu Zhao; William Matloff; Kaida Ning; Hosung Kim; Ivo D Dinov; Arthur W Toga
Journal:  Cereb Cortex       Date:  2019-09-13       Impact factor: 5.357

3.  The cannabis paradox: when age matters.

Authors:  Andrés Ozaita; Ester Aso
Journal:  Nat Med       Date:  2017-06-06       Impact factor: 53.440

4.  The Anti-Aging Protein Klotho Enhances Remyelination Following Cuprizone-Induced Demyelination.

Authors:  Ella Zeldich; Ci-Di Chen; Robin Avila; Satish Medicetty; Carmela R Abraham
Journal:  J Mol Neurosci       Date:  2015-06-12       Impact factor: 3.444

5.  Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho.

Authors:  Jon D Wright; Sung-Wan An; Jian Xie; Joonho Yoon; Nicole Nischan; Jennifer J Kohler; Noelynn Oliver; Carmay Lim; Chou-Long Huang
Journal:  FASEB J       Date:  2017-04-25       Impact factor: 5.191

Review 6.  Molecular and cellular aspects of age-related cognitive decline and Alzheimer's disease.

Authors:  Rikki Hullinger; Luigi Puglielli
Journal:  Behav Brain Res       Date:  2016-05-07       Impact factor: 3.332

7.  Serum Klotho, vitamin D, and homocysteine in combination predict the outcomes of Chinese patients with multiple system atrophy.

Authors:  Yue Guo; Xiao-Dong Zhuang; Wen-Biao Xian; Ling-Ling Wu; Ze-Na Huang; Xun Hu; Xiang-Song Zhang; Ling Chen; Xin-Xue Liao
Journal:  CNS Neurosci Ther       Date:  2017-06-19       Impact factor: 5.243

8.  Association of Klotho-VS Heterozygosity With Risk of Alzheimer Disease in Individuals Who Carry APOE4.

Authors:  Michael E Belloy; Valerio Napolioni; Summer S Han; Yann Le Guen; Michael D Greicius
Journal:  JAMA Neurol       Date:  2020-07-01       Impact factor: 18.302

9.  Peripheral levels of the anti-aging hormone Klotho in patients with depression.

Authors:  Alexander Sartorius; Maria Gilles; Anna-Maria Pfeifer; Michael Deuschle; Carolin Hoyer; Dieter Haffner; Maren Leifheit-Nestler; Laura Kranaster
Journal:  J Neural Transm (Vienna)       Date:  2019-05-04       Impact factor: 3.575

10.  G-395A polymorphism in the promoter region of the KLOTHO gene associates with reduced cognitive impairment among the oldest old.

Authors:  Qiukui Hao; Xiang Ding; Langli Gao; Ming Yang; Birong Dong
Journal:  Age (Dordr)       Date:  2016-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.